These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9685963)

  • 1. [Immunogenicity of the Heberbiovac-HB vaccine in the physically and mentally handicapped].
    Pedroso Flaquet P; Díaz González M; Rodríguez Lay L; Bravo González JR
    Rev Cubana Med Trop; 1997; 49(1):59-63. PubMed ID: 9685963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The immunogenicity of the Heberbiovac-HB vaccine in the elderly].
    Pedroso Flaquet P; Díaz González M; Rodríguez Lay L; Bravo González R
    Rev Cubana Med Trop; 1996; 48(3):200-3. PubMed ID: 9805052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunogenicity of the Heberbiovac-HB vaccine in children].
    Díaz González M; Chiang Macía A; Díaz Acosta D; Bravo González JR; Rodríguez Lay L; Pedroso Flaquet P; López-Chávez AU
    Rev Cubana Med Trop; 1996; 48(3):195-8. PubMed ID: 9805051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity of the Heberbiovac-HB vaccine in doses of 10.5 and 2.5 micrograms in 6-9-year-old students].
    Díaz González M; Navia Molina O; Urbino López-Chávez A; Rodríguez Lay L; Bravo González JR; Pedroso Flaquet P
    Rev Cubana Med Trop; 1999; 51(1):46-9. PubMed ID: 10887555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents.
    Schiff GM; Sherwood JR; Zeldis JB; Krause DS
    J Adolesc Health; 1995 Jan; 16(1):12-7. PubMed ID: 7742331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse reactions and immune response to Heberbiovac-HB vaccine administered to infants simultaneously with DPT and VA-MENGOC-BC].
    Díaz González M; Rodríguez Lay L; López-Chávez AU; Bravo González JR; Pedroso Flaquet P
    Rev Cubana Med Trop; 1997; 49(3):196-203. PubMed ID: 9685987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
    Liang Z; Li C; Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children.
    el-Sawy IH; Mohamed ON
    East Mediterr Health J; 1999 Sep; 5(5):922-32. PubMed ID: 10983531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled clinical trial comparing the safety and immunogenicity of a new adjuvanted hepatitis B vaccine with a standard hepatitis B vaccine.
    Dupont J; Altclas J; Lepetic A; Lombardo M; Vázquez V; Salgueira C; Seigelchifer M; Arndtz N; Antunez E; von Eschen K; Janowicz Z
    Vaccine; 2006 Nov; 24(49-50):7167-74. PubMed ID: 16884836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, single-blind comparison of the immunogenicity and reactogenicity of 20 micrograms and 10 micrograms doses of hepatitis B vaccine in adolescents.
    Poovorawan Y; Pongpunlert W; Theamboonlers A; Vimolgej L; Chumdermpadetsuk S; Vandepapeliere P; Safary A
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):255-9. PubMed ID: 8266226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative study between different regimens for administering 2 doses of the Cuban anti-hepatitis B vaccine].
    González-Griego Mde J; Cinza Z; Ortega A; Gali MM; Santoyo ME; García G; Delahanty A
    Rev Cubana Med Trop; 1998; 50(3):218-20. PubMed ID: 10349448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the response to the recombinant vaccine against hepatitis B virus in dialyzed and nondialyzed children with CRF using different doses and routes of administration.
    Vazquez G; Mendoza-Guevara L; Alvarez T; Aguilar A; Morales A; Rodriguez F; Solorzano F; Garcia-Lopez E; Muñoz O
    Adv Perit Dial; 1997; 13():291-6. PubMed ID: 9360702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.